retatrutide peptide 16 mg 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide - “Triple G” |
Description
Devos D, Hirsch E, Wyse R
Gke, R
The consequences are that the facial skin loses its firmness and elasticity, often resulting in a sunken appearance
Sometimes it feels like everyone is taking Ozempic or Wegovy or one of the other GLP1 agonist drugs now approved for weight loss by the FDA
Symptoms may include blurred vision, floaters, or spots
Plainsboro, NJ, Novo Nordisk, 2024 [Google Scholar] 4
